Replicel Life Sciences Inc - ESG Rating & Company Profile powered by AI
The report of Replicel Life Sciences Inc uses information from across the web as well as from available filings by Replicel Life Sciences Inc. Comprehensive ESG assessment of Replicel Life Sciences Inc are accessed by registering for free. The dashboard includes a Q&A section for Replicel Life Sciences Inc.
Replicel Life Sciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 8.0, social score of 2.7 and governance score of 2.7.
4.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 852 | Vaccibody AS | 4.6 | High |
| 852 | argenx SE | 4.6 | High |
| 868 | Replicel Life Sciences Inc | 4.5 | High |
| 868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
| 868 | Boiron SA | 4.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Replicel Life Sciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Replicel Life Sciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Replicel Life Sciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Replicel Life Sciences Inc offer flexible work?
Sign up for free to unlockDoes Replicel Life Sciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Replicel Life Sciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Replicel Life Sciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose water use targets?
Sign up for free to unlockDoes Replicel Life Sciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Replicel Life Sciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Replicel Life Sciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Replicel Life Sciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Replicel Life Sciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Replicel Life Sciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Replicel Life Sciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose its waste policy?
Sign up for free to unlockDoes Replicel Life Sciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose energy use targets?
Sign up for free to unlockDoes Replicel Life Sciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Replicel Life Sciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Replicel Life Sciences Inc
These potential risks are based on the size, segment and geographies of the company.
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.